Clidinium Bromide, designated by its CAS number 3485-62-9, is a compound of significant interest within the pharmaceutical industry. As a pharmaceutical intermediate, it plays a pivotal role in the complex processes leading to the creation of essential medicines. This article explores the fundamental chemical properties of Clidinium Bromide and its critical applications, particularly in the development of drugs for gastrointestinal health.

The compound presents as a white crystalline solid, a physical characteristic that aids in its identification and handling during manufacturing. Its chemical makeup is defined by the molecular formula C22H26BrNO3, and it possesses a molecular weight of approximately 432.35 g/mol. These specifications are crucial for chemists and manufacturers to ensure accurate formulation and predictable behavior in subsequent synthesis steps. The high purity, typically exceeding 97%, underscores its suitability as a pharmaceutical raw material, where consistency and quality are non-negotiable.

The therapeutic utility of Clidinium Bromide is largely attributed to its anticholinergic actions. This pharmacological profile makes it a key ingredient in antispasmodic medications. These drugs are prescribed to alleviate the symptoms associated with gastrointestinal distress, such as spasms and excessive acid production. Conditions like Irritable Bowel Syndrome (IBS) and peptic ulcers often benefit from treatments incorporating Clidinium Bromide, as it helps to relax the smooth muscles of the digestive tract and reduce gastric secretions.

The chemical synthesis of Clidinium Bromide is a specialized field, with manufacturers focusing on producing a high-quality intermediate that meets stringent pharmaceutical standards. The sourcing of this Clidinium Bromide for IBS treatment requires diligent vetting of suppliers to ensure product integrity and regulatory compliance. Its role extends beyond just being an ingredient; it is a foundational element in drug development, enabling the creation of effective treatments that improve patient quality of life.